Skip to content
HowShorted

Accelerate Diagnostics, Inc short interest in 2018

In 2018, Accelerate Diagnostics, Inc's disclosed short interest ran from 19.72% of shares outstanding on 12 Jan 2018 to 28.10% on 31 Dec 2018, a change of +8.38 percentage points. The year's high was 28.21% on 14 Dec 2018 and its low 19.52% on 31 Jan 2018, averaging 23.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 101.18 days on 13 Jul 2018. Full history: Accelerate Diagnostics, Inc.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Accelerate Diagnostics, Inc in 2018

2018 in figures

Start of year
19.72% (12 Jan 2018)
End of year
28.10% (31 Dec 2018)
Change
+8.38 pp
High
28.21% (14 Dec 2018)
Low
19.52% (31 Jan 2018)
Average
23.18%
Highest days to cover
101.18 (13 Jul 2018)
SEC filings marked
9

Every report in 2018

Accelerate Diagnostics, Inc short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 201819.72%42.78results (8-K)
31 Jan 201819.52%38.07
15 Feb 201820.54%35.92results (8-K)
28 Feb 201821.04%40.83
15 Mar 201821.43%58.4210-K filed
29 Mar 201821.50%55.47
13 Apr 201821.21%59.47
30 Apr 201821.52%92.01
15 May 201821.77%33.3110-Q filed, results (8-K)
31 May 201822.74%46.80
15 Jun 201822.55%49.18
29 Jun 201822.71%45.91
13 Jul 201822.59%101.18
31 Jul 201823.27%71.47
15 Aug 201823.63%53.82results (8-K), 10-Q filed
31 Aug 201824.20%81.35
14 Sep 201823.84%63.51
28 Sep 201823.74%56.40
15 Oct 201824.49%31.16
31 Oct 201824.17%37.62
15 Nov 201826.24%29.9810-Q filed, results (8-K)
30 Nov 201827.66%50.90
14 Dec 201828.21%46.10
31 Dec 201828.10%39.63

See also: Accelerate Diagnostics, Inc's full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.